Lansing Street Advisors Purchases 27 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Lansing Street Advisors boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 766 shares of the healthcare conglomerate’s stock after buying an additional 27 shares during the period. Lansing Street Advisors’ holdings in UnitedHealth Group were worth $388,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Accredited Investors Inc. raised its position in UnitedHealth Group by 9,235.4% during the third quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after purchasing an additional 776,516 shares during the period. Caisse DE Depot ET Placement DU Quebec raised its position in UnitedHealth Group by 129.7% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock valued at $601,951,000 after purchasing an additional 581,324 shares during the period. State Street Corp raised its position in UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after purchasing an additional 563,554 shares during the period. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in UnitedHealth Group during the third quarter valued at approximately $276,785,000. Finally, Canoe Financial LP purchased a new stake in UnitedHealth Group during the third quarter valued at approximately $216,166,000. 87.86% of the stock is owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 7.3 %

Shares of NYSE UNH opened at $465.58 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $428.46 billion, a PE ratio of 30.04, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The stock’s fifty day simple moving average is $519.27 and its two-hundred day simple moving average is $560.48. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the firm earned $5.83 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently weighed in on UNH. KeyCorp reiterated an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Piper Sandler reduced their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a report on Friday, January 10th. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.